W. L. GORE & ASSOCIATES, INC. GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
|
Back to Search Results |
|
Catalog Number TGM282810 |
Device Problem
Defective Device (2588)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 03/24/2024 |
Event Type
malfunction
|
Event Description
|
On 27-mar-2024, the fsa was notified by a physician of an event during a procedure on (b)(6) 2024.While treating a patient for a thoracic aortic aneurysm, the physician implanted a gore® tag® conformable thoracic stent graft with active control system tgm282810.The physician noticed that the lock wire was not attached to the handle.He attempted to deploy the device, but the distal end would not deploy properly.It was decided to remove the device and complete the procedure with another device.The procedure was completed with no further issues, and the patient tolerated the procedure.No gore fsa was present at the procedure.The device will be returned for evaluation.
|
|
Manufacturer Narrative
|
W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Manufacturer Narrative
|
Additional investigation determined no product problem or deficiency caused or contributed to an adverse event/incident for the patient; the initial medwatch and any supplemental report submitted under manufacturer report number 2017233-2024-04858 was submitted in error and is hereby retracted.
|
|
Search Alerts/Recalls
|
|
|